Pfizer Warns of Risks from its Painkiller

October 16, 2004 - Pfizer warned doctors that one of its best-selling painkillers, Bextra, might increase the risk of heart attack or stroke in coronary artery bypass surgery patients. Read More

Response to Merck’s Press Conference regarding Vioxx

October 13, 2004 - Merck's press conference was very disappointing, according to Andy Birchfield, "Instead of accepting responsibility for putting a dangerous drug on the market and keeping it there for so... Read More

Lawsuits looming as Vioxx Recalled

October 13, 2004 - Lawsuits. Lawsuits. Lawsuits. And they're coming fast. The recall came after testing revealed the risk of heart attack or stroke doubled for those taking Vioxx. Read More

Merck’s Pain Sharpens

October 11, 2004 - The final bill for Merck's Vioxx is just beginning to be toted up before it pulled Vioxx off the market because of the cardiac risks the painkiller could pose to long-term users. Read More

Vioxx Lawsuits may be difficult to Prove

October 10, 2004 - Evelyn Irvin Plunkett said she remembers the day her husband starting taking Vioxx for back pain. It was April 15, 2001. Read More

FDA accused of silencing Vioxx Warnings

October 8, 2004 - The FDA silenced one of its drug experts who raised safety concerns weeks before Merck & Co. yanked the blockbuster drug Vioxx due to increased risks for heart attack and strokes. Read More

Merck braces for wave of Vioxx Lawsuits

October 3, 2004 - The flood of phone calls to plaintiffs' lawyers began soon after pharmaceutical giant Merck & Co. announced that it would withdraw its painkiller Vioxx from the market because of safety... Read More

Merck braces for another Deluge of Lawsuits by Vioxx Users

October 3, 2004 - Following Merck & Co.'s withdrawal of the blockbuster painkiller Vioxx, patients, shareholders and even the company began scrambling to figure out their next moves. Read More

Merck to face Billions in Lawsuits

October 2, 2004 - Merck could face legal liabilities of up to $10B following its worldwide withdrawal of the blockbuster pain drug Vioxx, according to some analysts' estimates. Read More

A Blow to Efforts to Close in on Rivals

October 1, 2004 - Merck & Company's decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company. Read More

back to top